AI assistant
INVION LIMITED — Director's Dealing 2014
Nov 26, 2014
65148_rns_2014-11-26_50746141-a593-40fd-bce4-d225a96601cb.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity INVION LIMITED ABN 76 094 730 417
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | DR GREG COLLIER |
|---|---|
| Date of last notice | 2 April 2014 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Barwon Biotechnology Pty Ltd of which Dr Collier is a director and shareholder. Beacon Super Fund Pty Ltd ATF Beacon Super Fund of which Dr Collier is a director and beneficiary. |
| Date of change | 24 November 2014 |
| No. of securities held prior to change | 15,361,352 fully paid Ordinary Shares 10,000,000 Share Options with an exercise price of $0.10 and an expiry date of 9 November 2017. |
| Class | Fully paid ordinary shares |
| Number acquired | 400,000 fully paid Ordinary Shares |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Number disposed | nil |
|---|---|
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
$0.0585 per share acquired |
| No. of securities held after change | 15,761,352 fully paid Ordinary Shares 10,000,000 Share Options with an exercise price of $0.10 and an expiry date of 9 November 2017. |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
On market trade. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | n/a |
|---|---|
| Nature of interest | n/a |
| Name of registered holder (if issued securities) |
n/a |
| Date of change | n/a |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
n/a |
| Interest acquired | n/a |
| Interest disposed | n/a |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
n/a |
| Interest after change | n/a |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No. |
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
n/a |
| If prior written clearance was provided, on what date was this provided? |
n/a |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3